Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Primary Immunodeficiencies and Cancers Publisher



Hedayat M1 ; Alherz W2 ; Aghamohammadi A3 ; Nichols KE4 ; Rezaei N5, 6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Division of Immunology, Boston Children’s Hospital, Harvard Medical School, Boston, AL, United States
  2. 2. Department of Pediatrics, Faculty of Medicine, Kuwait University, Safat, Kuwait
  3. 3. Research Center for Immunodefi ciencies, Department of Allergy and Immunology, Children’s Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, 14194, Iran
  4. 4. Department of Oncology, St. Jude Children’s Research Hospital, Memphis, 38105, TN, United States
  5. 5. Research Center for Immunodeficiencies, Children’s Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Dr Qarib St, Keshavarz Blvd, Tehran, 14194, Iran
  6. 6. Department of Immunology, School of Medicine, and Molecular Immunology Research Center, Tehran University of Medical Sciences, Dr Qarib St, Keshavarz Blvd, Tehran, 14194, Iran

Source: Cancer Immunology: A Translational Medicine Context Published:2015


Abstract

Primary immunodeficiencies (PIDs) comprise a heterogeneous group of genetic disorders, predisposing to frequent and severe infections, autoimmunity, and cancer. In recent years, the tendency to develop cancers has increased in parallel with improved life expectancy, largely due to effective immunoglobulin replacement and other supportive therapies. The overall risk for developing malignancies in children with PIDs is 4a€”25%, with lymphomas representing up to 60% of cancers. Defective immunosurveillance mechanisms and infection with oncogenic viruses have significant contributory roles in many cases. In this chapter, we review our understanding of the spectrum and pathogenesis of malignancies in the context of immunodeficiency syndromes, with emphasis on the epidemiologic data, clinical patterns, and potential importance of cancer screening for patients with specific PIDs. © Springer-Verlag Berlin Heidelberg 2015.
1. Inborn Errors of Immunity and Cancers, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
3. Common Presentations and Diagnostic Approaches, Stiehm's Immune Deficiencies: Inborn Errors of Immunity (2020)
5. Congenital Neutropenia and Primary Immunodeficiency Diseases, Critical Reviews in Oncology/Hematology (2019)
Experts (# of related papers)
Other Related Docs
9. Pulmonary Manifestations of Predominantly Antibody Deficiencies, Pulmonary Manifestations of Primary Immunodeficiency Diseases (2018)
18. Autoimmunity in Primary Antibody Deficiencies, International Archives of Allergy and Immunology (2017)
19. Pulmonary Manifestations of Other Well-Defined Immunodeficiencies, Pulmonary Manifestations of Primary Immunodeficiency Diseases (2018)
20. Autoimmunity in Patients With Selective Iga Deficiency, Journal of Investigational Allergology and Clinical Immunology (2015)
24. Infectious and Noninfectious Pulmonary Complications in Patients With Primary Immunodeficiency Disorders, Journal of Investigational Allergology and Clinical Immunology (2017)
26. The Heterogeneous Pathogenesis of Selective Immunoglobulin a Deficiency, International Archives of Allergy and Immunology (2019)
28. Primary Immunodeficiency and Thrombocytopenia, International Reviews of Immunology (2022)
30. The Diagnosis of Hyper Immunoglobulin E Syndrome Based on Project Management, Iranian Journal of Allergy# Asthma and Immunology (2015)
31. Hyper Ige Syndromes: A Clinical Approach, Clinical Immunology (2022)
32. Defects in Innate Immunity: Receptors and Signaling Components, Encyclopedia of Infection and Immunity (2022)
36. A Review on Defects of Dendritic Cells in Common Variable Immunodeficiency, Endocrine# Metabolic and Immune Disorders - Drug Targets (2017)
37. Application of Flow Cytometry in Predominantly Antibody Deficiencies, Endocrine# Metabolic and Immune Disorders - Drug Targets (2021)
42. Agammaglobulinemia: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management, Endocrine# Metabolic and Immune Disorders - Drug Targets (2020)
45. Monogenic Mutations Associated With Iga Deficiency, Expert Review of Clinical Immunology (2016)
47. Primary Antibody Deficiency in a Tertiary Referral Hospital: A 30-Year Experiment, Journal of Investigational Allergology and Clinical Immunology (2015)
50. Autoimmunity in Primary T-Cell Immunodeficiencies, Expert Review of Clinical Immunology (2016)